Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Anal Bioanal Chem ; 411(12): 2493-2509, 2019 May.
Artículo en Inglés | MEDLINE | ID: mdl-30911800

RESUMEN

Inhalation of Bacillus anthracis spores can cause a rapidly progressing fatal infection. B. anthracis secretes three protein toxins: lethal factor (LF), edema factor (EF), and protective antigen (PA). EF and LF may circulate as free or PA-bound forms. Both free EF (EF) and PA-bound-EF (ETx) have adenylyl cyclase activity converting ATP to cAMP. We developed an adenylyl cyclase activity-based method for detecting and quantifying total EF (EF+ETx) in plasma. The three-step method includes magnetic immunocapture with monoclonal antibodies, reaction with ATP generating cAMP, and quantification of cAMP by isotope-dilution HPLC-MS/MS. Total EF was quantified from 5PL regression of cAMP vs ETx concentration. The detection limit was 20 fg/mL (225 zeptomoles/mL for the 89 kDa protein). Relative standard deviations for controls with 0.3, 6.0, and 90 pg/mL were 11.7-16.6% with 91.2-99.5% accuracy. The method demonstrated 100% specificity in 238 human serum/plasma samples collected from unexposed healthy individuals, and 100% sensitivity in samples from 3 human and 5 rhesus macaques with inhalation anthrax. Analysis of EF in the rhesus macaques showed that it was detected earlier post-exposure than B. anthracis by culture and PCR. Similar to LF, the kinetics of EF over the course of infection were triphasic, with an initial rise (phase-1), decline (phase-2), and final rapid rise (phase-3). EF levels were ~ 2-4 orders of magnitude lower than LF during phase-1 and phase-2 and only ~ 6-fold lower at death/euthanasia. Analysis of EF improves early diagnosis and adds to our understanding of anthrax toxemia throughout infection. The LF/EF ratio may also indicate the stage of infection and need for advanced treatments.


Asunto(s)
Carbunco/patología , Antígenos Bacterianos/sangre , Bacillus anthracis/patogenicidad , Toxinas Bacterianas/sangre , Cromatografía Líquida de Alta Presión/métodos , Infecciones del Sistema Respiratorio/patología , Espectrometría de Masas en Tándem/métodos , Toxemia/patología , Adenosina Trifosfato/metabolismo , Animales , Carbunco/sangre , Estudios de Casos y Controles , AMP Cíclico/biosíntesis , Progresión de la Enfermedad , Ensayo de Inmunoadsorción Enzimática , Humanos , Límite de Detección , Macaca mulatta , Reacción en Cadena de la Polimerasa , Infecciones del Sistema Respiratorio/sangre , Toxemia/sangre , Toxemia/microbiología
2.
Anal Bioanal Chem ; 407(10): 2847-58, 2015 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-25673244

RESUMEN

Inhalation anthrax has a rapid progression and high fatality rate. Pathology and death from inhalation of Bacillus anthracis spores are attributed to the actions of secreted protein toxins. Protective antigen (PA) binds and imports the catalytic component lethal factor (LF), a zinc endoprotease, and edema factor (EF), an adenylyl cyclase, into susceptible cells. PA-LF is termed lethal toxin (LTx) and PA-EF, edema toxin. As the universal transporter for both toxins, PA is an important target for vaccination and immunotherapeutic intervention. However, its quantification has been limited to methods of relatively low analytic sensitivity. Quantification of LTx may be more clinically relevant than LF or PA alone because LTx is the toxic form that acts on cells. A method was developed for LTx-specific quantification in plasma using anti-PA IgG magnetic immunoprecipitation of PA and quantification of LF activity that co-purified with PA. The method was fast (<4 h total time to detection), sensitive at 0.033 ng/mL LTx in plasma for the fast analysis (0.0075 ng/mL LTx in plasma for an 18 h reaction), precise (6.3-9.9% coefficient of variation), and accurate (0.1-12.7%error; n ≥ 25). Diagnostic sensitivity was 100% (n = 27 animal/clinical cases). Diagnostic specificity was 100% (n = 141). LTx was detected post-antibiotic treatment in 6/6 treated rhesus macaques and 3/3 clinical cases of inhalation anthrax and as long as 8 days post-treatment. Over the course of infection in two rhesus macaques, LTx was first detected at 0.101 and 0.237 ng/mL at 36 h post-exposure and increased to 1147 and 12,107 ng/mL in late-stage anthrax. This demonstrated the importance of LTx as a diagnostic and therapeutic target. This method provides a sensitive, accurate tool for anthrax toxin detection and evaluation of PA-directed therapeutics.


Asunto(s)
Carbunco/diagnóstico , Antígenos Bacterianos/análisis , Toxinas Bacterianas/análisis , Infecciones del Sistema Respiratorio/diagnóstico , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción/métodos , Secuencia de Aminoácidos , Animales , Carbunco/tratamiento farmacológico , Antibacterianos/uso terapéutico , Especificidad de Anticuerpos , Antígenos Bacterianos/sangre , Antígenos Bacterianos/inmunología , Toxinas Bacterianas/sangre , Toxinas Bacterianas/inmunología , Humanos , Inmunoprecipitación/métodos , Macaca mulatta , Magnetismo , Datos de Secuencia Molecular , Reproducibilidad de los Resultados , Infecciones del Sistema Respiratorio/tratamiento farmacológico , Sensibilidad y Especificidad , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA